Howitt L, Grayson TH, Morris MJ, Sandow SL, Murphy TV. Dietary obesity increases NO and inhibits BK Ca-mediated, endothelium-dependent dilation in rat cremaster muscle artery: association with caveolins and caveolae. Am J Physiol Heart Circ Physiol 302: H2464 -H2476, 2012. First published April 6, 2012 doi:10.1152/ajpheart.00965.2011.-Obesity is a risk factor for hypertension and other vascular disease. The aim of this study was to examine the effect of diet-induced obesity on endothelium-dependent dilation of rat cremaster muscle arterioles. Male Sprague-Dawley rats (213 Ϯ 1 g) were fed a cafeteria-style high-fat or control diet for 16 -20 wk. Control rats weighed 558 Ϯ 7 g compared with obese rats 762 Ϯ 12 g (n ϭ 52-56; P Ͻ 0.05). Diet-induced obesity had no effect on acetylcholine (ACh)-induced dilation of isolated, pressurized (70 mmHg) arterioles, but sodium nitroprusside (SNP)-induced vasodilation was enhanced. ACh-induced dilation of arterioles from control rats was abolished by a combination of the KCa blockers apamin, 1-[(2-chlorophenyl)diphenylmethyl]-1H-pyrazole (TRAM-34), and iberiotoxin (IBTX; all 0.1 mol/l), with no apparent role for nitric oxide (NO). In arterioles from obese rats, however, IBTX had no effect on responses to ACh while the NO synthase (NOS)/guanylate cyclase inhibitors N -nitro-L-arginine methyl ester (L-NAME; 100 mol/l)/1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one (ODQ; 10 mol/l) partially inhibited ACh-induced dilation. Furthermore, NOS activity (but not endothelial NOS expression) was increased in arteries from obese rats. L-NAME/ODQ alone or removal of the endothelium constricted arterioles from obese but not control rats. Expression of caveolin-1 and -2 oligomers (but not monomers or caveolin-3) was increased in arterioles from obese rats. The number of caveolae was reduced in the endothelium of arteries, and caveolae density was increased at the ends of smooth muscle cells from obese rats. Dietinduced obesity abolished the contribution of large-conductance Ca 2ϩ -activated K ϩ channel to ACh-mediated endothelium-dependent dilation of rat cremaster muscle arterioles, while increasing NOS activity and inducing an NO-dependent component. (72) . Many of these enzymes and channels are localized within caveolae, as cholesterol-rich invaginations of the plasma membrane (10). Caveolins, the structural proteins of caveolae, have an established role in modulating vascular signaling mechanisms including NO synthase (NOS) and BK Ca activity (1, 13, 20) .
large-conductance Ca 2ϩ -activated K ϩ channel; nitric oxide IMPAIRED VASCULAR RESPONSES to vasodilator stimuli, including significantly impaired endothelium-dependent dilation, are frequently observed in both obese individuals (3, 5) and animal models of obesity (15, 18) . Increased sensitivity of vessels to vasoconstrictor stimuli and/or decreased responses to vasodilators may contribute to obesity-induced hypertension and other vascular disease states (4, 24) . Endothelium-derived vasodilators include nitric oxide (NO) and prostacyclin (PGI 2 ) in addition to non-NO/PGI 2 endothelium-dependent hyperpolarization (EDH) of vascular smooth muscle (22, 59) . EDH of smooth muscle and the consequent vasodilation may be brought about by a variety of chemical factors released by the endothelium (EDHFs), or hyperpolarization of the endothelium can be transferred to smooth muscle cells via myoendothelial gap junctions at microdomain sites (22, 28, 59 -61) . While there are several possible mechanisms by which EDH may occur, vascular K ϩ channels play a crucial role in mediating their effects. The large-conductance, Ca 2ϩ -activated K ϩ channel (BK Ca ) plays an important role in many vascular beds (21, 41, 43) , along with SK Ca and IK Ca , which are primarily expressed in endothelial cells and mediate EDH. BK Ca are expressed in the smooth muscle of arteries (32, 34, 58) , including the rat cremaster muscle arteriole (32) , and may be activated by endothelium-derived substances such as epoxyeicosatrienoic acid (EETs; Ref. 8) , NO and PGI 2 (51) , and H 2 O 2 (70) . Nonendothelium-dependent nitro-vasodilators and ␤-adrenoceptor agonists may also activate BK Ca (72) . Many of these enzymes and channels are localized within caveolae, as cholesterol-rich invaginations of the plasma membrane (10) . Caveolins, the structural proteins of caveolae, have an established role in modulating vascular signaling mechanisms including NO synthase (NOS) and BK Ca activity (1, 13, 20) .
Studies on the impact of obesity on endothelium-dependent vasodilation have focused on impaired NO-mediated responses and, in particular, the altered endothelial NOS (eNOS) activity and NO bioavailability associated with inflammatory mediators and oxidative stress (24, 53) . Decreased NO-dependent vasodilation, as an apparent consequence of oxidative stress, has been observed in animal models of obesity (16, 18, 25, 26) . In smaller arteries and arterioles, however, particularly those in skeletal muscle (43) , NO generally makes a relatively minor contribution to endothelium-dependent vasodilation, with EDH having a more significant role (31, 56) . Relatively few studies have examined the effect of diet-induced obesity on EDHmediated vasodilation, and most of these have utilized genetic models of obesity (6, 7, 17, 18, 39) as opposed to dietary interventions that may be more representative of the human condition. Furthermore, the association between the vascular adaptations to obesity and expression of caveolae and caveolins has been little explored. As caveolae are cholesterol-rich, dietary obesity and the accompanying changes in plasma lipid profile could be expected to have an impact on their distribution and function. In coronary arterioles from rats maintained on a high-fat diet (HFD), caveolin-1 expression was decreased and BK Ca -mediated dilation enhanced (20) and similar observations were made in caveolin-1 knockout mice (1, 20) . It is worth noting these studies measured the expression of caveolin-1 monomer only, rather than the high molecular-weight, oligomerized form of caveolin-1 present in caveolae (35) .
A recent study (32) in diet-induced obese rats showed that the expression of BK Ca ␤ 1 -subunit and BK Ca function was reduced in cremaster muscle arterioles, a vessel where BK Ca plays a critical role in endothelium-mediated vasodilation (43) . The hypothesis underlying the present study was that reduced BK Ca ␤ 1 -subunit activity, as a consequence of dietary obesity, reduced BK Ca -mediated endothelium-dependent vasodilation of rat cremaster muscle arterioles. It was further hypothesized that these changes were accompanied by alterations in the distribution and expression of caveolae and caveolin-1.
MATERIALS AND METHODS
Animals. Studies were performed in male Sprague-Dawley rats (starting age 6 -7 wk; 213 Ϯ 1 g; n ϭ 108) housed three to four per cage under a 12-h light-dark cycle and temperature maintained at ϳ21°C. Experimental protocols were approved by the University of New South Wales Animal Care and Ethics Committee.
Diet and sample collection. Rats were fed either standard rat chow (Gordon's Specialty Stockfeeds; Yanderra, NSW, Australia) or a highly palatable cafeteria-style HFD (described previously in Ref. 29) and tap water ad libitum for 16 -20 wk. The HFD consisted of foods such as pies, cakes, and dim sims in addition to standard chow. Body weight was measured weekly, and 24-h food intake (kJ) was measured every 2-3 wk. At the end of the diet period, rats were anesthetized with sodium thiopentone (100 mg/kg ip; Abbott, Kurnell, NSW, Australia). Blood samples were taken by cardiac puncture, and blood glucose was measured immediately (Accu-Chek Advantage; Roche Diagnostics, Castle Hill, NSW, Australia). Plasma samples were stored at Ϫ20°C for subsequent measurement of plasma insulin and leptin (Millipore, North Ryde, NSW, Australia). Left retroperitoneal (Rp) fat was removed and weighed.
Isolated vessel preparation. Both the left and right cremaster muscles were dissected and removed from the animal and transferred to a cold (4°C) dissecting dish containing dissecting buffer (in mmol/l: 3 MOPS, 145 NaCl, 5 KCl, 2.5 CaCl2, 1 MgSO4, 1 NaH2PO4, 0.02 EDTA, 2 pyruvate, 5 glucose, and 1% BSA; Bovogen Biologicals, Essendon, VIC, Australia). A segment of the first order arteriole was isolated from the muscle and transferred to a tissue bath as described previously (67) . The tissue bath contained modified Krebs buffer solution (in mmol/l: 111 NaCl, 25.7 NaHCO 3, 4.9 KCl, 2.5 CaCl2, 1.2 MgSO4, 1.2 KH2PO4, 11.5 glucose, and 10 HEPES) that had been bubbled with 5% CO2-95% N2. The isolated arteriole was cannulated onto glass micropipettes and secured with 10 -0 sutures (Alcon Laboratories, Frenchs Forest, NSW, Australia).
Vessels were checked for leaks, and only vessels able to hold 120 mmHg for 20 -30 s were used. The vessel was superfused (3 ml/min) with warmed Krebs solution (34°C) and initially pressurized to 40 mmHg. The vessel was allowed to develop spontaneous tone and was then equilibrated at 70 mmHg for 30 min. Intraluminal diameter was measured using video microscopy and calibrated video calipers. Pressure was measured with a pressure transducer (Abbott Critical Care Systems). Data were recorded with a Powerlab (model 4/25) and Chart v5.5.1 software (ADInstruments, Bella Vista, NSW, Australia).
Experimental protocols. Four consecutive, cumulative concentration-response curves to ACh (0.001-3 mol/l) were performed in the absence and presence of the NOS and guanylate cyclase inhibitors N -nitro-L-arginine methyl ester hydrochloride (L-NAME; 100 mol/l) and 1H- [1, 2, 4] oxadiazolo [4,3-a] quinoxalin-1-one (ODQ; 10 mol/l), respectively; and with the sequential addition of the IK Ca and SKCa inhibitors 1-[(2-chlorophenyl)diphenylmethyl]-1H-pyrazole (TRAM-34, 0.1 mol/l; Toronto Research Chemicals, Ontario, Canada) and apamin (AP; 0.1 mol/l), respectively; and then lastly the BK Ca inhibitor iberiotoxin (IBTX, 0.1 mol/l). After the addition of L-NAME and ODQ, TRAM-34, and AP, the vessel was allowed to equilibrate for 20 min. After the addition of IBTX, the vessel was equilibrated for 10 min. In a separate series of experiments, the diameter of vessels were measured before and after treatment with L-NAME (100 mol/l) alone, followed by the addition of ODQ (10 mol/l).
Cumulative concentration-response curves to 11,12-EET [(Ϯ)11(12)-EpETrE; 1-10 mol/l; Cayman Chemical] and sodium nitroprusside (SNP; 0.001-10 mol/l) and responses to 1 mmol/l 8-bromoguanosine 3=,5=-cyclic monophosphate sodium salt (8-bromo-cGMP) were obtained alone and after a 10-min treatment period with IBTX (0.1 mol/l).
To functionally ablate the endothelium, responses to ACh (1 mol/l) and adenosine (10 and 100 mol/l) were measured after vessels developed myogenic tone at 70 mmHg. The lumen of the vessel was then perfused with air (ϳ1 ml). Removal of the endothelium was confirmed by abolition of responses to ACh with no effect on responses to adenosine (see Ref. 48) . At the conclusion of each experiment, the passive diameter was measured in a nominally Ca 2ϩ -free Krebs solution (no added CaCl 2 and 2 mmol/l EGTA).
Western blotting. First-order cremaster muscle arterioles were dissected and stored in liquid nitrogen. As the arterioles are small, vessels were pooled and each sample for assay contained between three and nine arterioles. The arterioles were ground in liquid nitrogen using a pestle and mortar, resuspended in PBS pH 7.4 containing complete protease inhibitor cocktail (Roche, Castle Hill, NSW, Australia), and centrifuged (3,000 g, 4°C, 5 min). The supernatant was removed and placed on ice, and the pellet was snap frozen in liquid nitrogen and processed again as above. Following the second spin, the supernatants were pooled and centrifuged (25,000 g, 4°C, 1 h) and the supernatant, enriched in cytosolic proteins, was aliquoted, snap frozen in liquid nitrogen and stored at Ϫ80°C. The membrane-enriched pellet was carefully resuspended in PBS containing 0.1% Triton X-100 and protease inhibitor cocktail, aliquoted, snap frozen in liquid nitrogen, and stored at Ϫ80°C. Protein concentration of the samples was determined using the Bradford protein assay (Bio-Rad, Gladesville, NSW, Australia).
Aliquots of protein extracts (5 g protein unless otherwise indicated) were dissolved in lithium dodecyl sulfate sample buffer (0.5% lithium dodecyl sulfate, 62.5 mmol/l Tris·HCl, 2.5% glycerol, and 0.125 mmol/l EDTA pH 8.5) for 10 min at 70°C, according to the manufacturer's instructions (Invitrogen, Mount Waverley, VIC, Australia). Notably, such conditions preserve homo-and hetero-oligomeric complexes of caveolins as shown previously (35, 46, 62, 64) . The samples were separated by electrophoresis in 4 -12% bis-Tris polyacrylamide gels using MES SDS running buffer and electroblotted onto PVDF membranes overnight at 4°C. Following transfer, blots were thoroughly washed, blocked and probed with characterized primary antibody and specific binding was visualized using alkaline phosphatase-conjugated secondary antibody and chemiluminescence according to the manufacturer's instructions (Invitrogen, Mount Waverley, VIC, Australia). The sources of primary antibodies and dilutions were as follows: NOS3 (eNOS) mouse monoclonal BD Transduction 610297 1:1000; caveolin-1 rabbit affinity purified polyclonal Santa Cruz sc-894, 1:1000; caveolin-2 mouse monoclonal BD Transduction 610685, 1:1000; caveolin-3 goat affinity purified polyclonal Santa Cruz sc-7665, 1:500; and ␤-actin rabbit affinity purified polyclonal Sigma A2066, 1:1000 (St. Louis, MO).
The intensity of the band corresponding to each full length protein was quantified by digital densitometry using ImageJ software (National Institutes of Health, Bethesda, MD). Relative intensity for each full-length band was determined by comparison with the intensity of actin staining. The resulting ratios for control and obese animals are expressed as means Ϯ SE.
To demonstrate specificity, each antibody was incubated with its cognate peptide to block specific binding. For caveolins-1 and -3, peptide was added to antibody in a 1:1 ratio (wt/wt), mixed, and incubated at 37°C for 1 h and then overnight at 4°C. The blocked antibody was then used in Western blotting detection as described above. Peptides are not available for the monoclonal antibodies specific to caveolin-2, and eNOS and these antibodies have been shown to be highly specific in previous studies (12, 71) .
Measurement of NOS enzyme activity. NOS activity was assayed by conversion of radiolabeled arginine to citrulline using a detection kit (Cayman Chemical). Pooled samples of first order cremaster muscle arterioles from between 4 and 11 animals/n (n ϭ 5 of each) were dissected and stored in liquid nitrogen. The vessels were ground in liquid nitrogen using a mortar and pestle and then mixed in homogenization solution and centrifuged (25, 000 g, 4°C, 1 h) . The supernatant was removed and placed on ice, and the pellet was resuspended in homogenization solution. Protein concentration of the samples was determined using the Bradford protein assay (Bio-Rad). Samples were stored at Ϫ80°C. Total NOS enzyme activity of each sample was measured in duplicate by the conversion of L-
3 H]citrulline following the manufacturer's instructions. As a control, neuronal NOS (5 l substituted for cremaster muscle arteriole sample) was added to the reaction mix in the absence and presence of the NOS inhibitor N G -nitro-L-arginine (1 mmol/l). The reaction mix (100 l) was added to 4 ml of scintillation fluid (Ultima Flo; PerkinElmer) and thoroughly mixed. Radioactivity was measured with a Packard Tri-Carb liquid scintillation counter (PerkinElmer). Data are expressed as a %conversion ϭ [(CPM sample Ϫ CPM background)/CPM total] ϫ 100, where CPM is counts per minute.
Measurement of cGMP by ELISA. Pooled samples of first order cremaster muscle arterioles from between four and eight animals/n (n ϭ 4 of each) were dissected and stored in liquid nitrogen. The vessels were ground in liquid nitrogen using a mortar and pestle and then mixed in homogenization solution (Assay Designs) and centrifuged (25,000 g, 4°C, 1 h). The supernatant was removed and placed on ice. Protein concentration of the samples was determined using the Bradford protein assay (Bio-Rad). Samples were stored at Ϫ80°C. The concentration of cGMP was measured using an ELISA kit (acetylated format) following the manufacturer's instructions (Assay Designs). Optical density was measured at 405 nm with a plate reader (model 680XR) and microplate manager software (v5.2.1; Bio-Rad).
Immunohistochemistry and electron microscopy. Short segments of first-order arterioles from the cremaster muscle were dissected and pinned to a dish containing Sylgard (Dow Corning). Vessels were fixed in 2% fresh paraformaldehdye or cold acetone for 10 min and washed with PBS (3 ϫ 5 min). Vessels were preincubated for 2 h in a primary blocking buffer containing 1% BSA (Bovogen Biologicals, Essendon, VIC, Australia) and 0.1% Triton X-100 in PBS. Vessels were incubated overnight at 4°C in primary antibodies (as above, dilutions 1:200 plus BKCa-␣ rabbit affinity purified polyclonal Alomone APC-107, 1:100) diluted in primary blocking buffer. After being washed in PBS (3 ϫ 5 min), vessels were incubated in fluorescent antibody conjugates (1:100) corresponding to the respective primary antibody, diluted in secondary blocking buffer (0.01% Triton X-100 in PBS) for 2 h at room temperature in the dark. After being washed in PBS (3 ϫ 5 min), vessels were mounted using anti-fade mounting medium (DakoCytomation, Campbellfield, VIC, Australia) and imaged in a confocal microscope (Olympus FV1000, North Ryde, NSW, Australia), using appropriate filters and uniform settings. Single section scans (0.1-0.2 m) were made to construct the confocal stacks shown. Mounting media for selected preparations contained 0.001% propidium iodide to clarify cell layer patency. Controls for antibody specificity involved omission of the primary antibody and preincubation with a 10-fold excess of peptide, where available.
Tissue preparation for electron microscopy was as described previously (32, 57) . In brief, first order cremaster muscle arterioles from control and obese rats (n ϭ 10, each from a different animal) were dissected from perfusion fixed rats (1% paraformaldehyde, 3% glutaraldehyde in 0.1 mmol/l sodium cacodylate buffer, with 10 mmol/l betaine, pH 7.4), embedded, sectioned, and imaged at ϫ10 -40k on a Phillips 7100 transmission electron microscope at 16 megapixel resolution (camera from Scientific Instruments and Applications, Duluth, MN). Quantitative measurements of wall properties were made from vessel cross sections cut 90°perpendicular to the longitudinal vessel axis from ultrastructural montages taken at ϫ1.5-2.5k at 16 megapixel resolution. CellR software (Olympus) was used for gross quantitative measurements.
Caveolae were defined as omega-shaped membrane invaginations (as "true" caveolae), and as "enclosed" submembranous caveolae, of a similar-size, but as apparent vesicles, not at, but within 300 nm of the endothelial and smooth muscle cell surface (54) . Caveolae sizes from cremaster arteriole endothelial and smooth muscle cells of each of 10 different obese and control animals were measured from electron micrographs. The density of true and submembranous caveolae, not at the end of cell profiles, was counted from randomly selected 20-m long regions of endothelial and smooth muscle cell membrane. Due to apparent localization of caveolae at some sites and in particular, at the ends of longitudinal smooth muscle cell profiles, the density of caveolae (as above) was separately counted from 5-m long regions at the ends of six of the longest smooth muscle cell profiles from each of five arterioles, each from a different animal.
Drugs and chemicals. All chemicals were obtained from SigmaAldrich, except where specifically stated above. ODQ and TRAM-34 were dissolved in DMSO to make a 10 mmol/l stock solution and stored at Ϫ20°C. AP, IBTX, and 8-bromo-cGMP were dissolved in distilled water to make a 100 mol/l, 10 mol/l, and 10 mmol/l stock solution respectively. All were stored at Ϫ20°C. (Ϯ)11(12)-EpETrE (312 mol/l in ethanol) was stored at Ϫ20°C. ACh, SNP, and L-NAME stock solutions were prepared fresh daily and dissolved in Krebs buffer. All stock solutions were diluted in Krebs buffer to achieve the final concentration. Vehicle solutions had no effect on vessel responses.
Statistical analysis. Results are expressed as means Ϯ SE. Active diameter is expressed as a percentage of the passive diameter observed in nominally Ca 2ϩ -free Krebs solution. Half-maximal effective concentration (EC50) was calculated by nonlinear regression analysis of individual concentration-response curves (GraphPad Prism v5). Data were analyzed using a two-way ANOVA with Bonferroni posttests followed by t-test for individual groups of data or one-way ANOVA with Bonferroni posttests or t-test alone where warranted (GraphPad Prism v5). P Ͻ 0.05 was considered significant.
RESULTS

Composition of HFD and its effect on body weight, adiposity, and metabolic parameters.
During the diet period, the daily energy intake of animals maintained on the HFD was significantly increased compared with control (683 Ϯ 17 vs. 330 Ϯ 5 kJ·rat Ϫ1 ·day
Ϫ1
, respectively; P Ͻ 0.05; unpaired t-test, n ϭ 52-56 of each). The energy intake of animals maintained on the HFD for this study consisted of 31.5 Ϯ 1.1% energy from fat. At the end of the diet period, the obese (HFD) animals weighed 762 Ϯ 12 g compared with control 558 Ϯ 7 g (P Ͻ 0.05, unpaired t-test; n ϭ 52-56 of each), an increase of ϳ35%. The HFD animals had significantly increased retroperitoneal fat both as net (g) and when expressed as a percentage of total body weight (control diet: 6.8 Ϯ 0.3 g/1.2 Ϯ 0.1%; HFD: 22.3 Ϯ 0.9 g/2.9 Ϯ 0.1%), while blood glucose (control: 8.2 Ϯ 0.2; HFD: 10.6 Ϯ 0.4 mmol/l), plasma insulin (control: 5.9 Ϯ 0.8; HFD: 13.4 Ϯ 0.8 ng/ml), and leptin (control: 5.9 Ϯ 0.3; HFD: 9.3 Ϯ 0.2 ng/ml) were also significantly increased in these animals (all P Ͻ 0.05, unpaired t-tests; n ϭ 49 -56).
Effect of diet-induced obesity on cremaster muscle arteriole diameter. At 70 mmHg, the luminal diameters of cremaster muscle arterioles with myogenic tone from control rats (80.9 Ϯ 1.8 m) was not significantly different from those from obese rats (84.4 Ϯ 2.4 m; n ϭ 52-56 of each; P Ͼ 0.05, unpaired t-test). The passive (maximum) diameter of arterioles from obese rats was significantly larger than control (179.5 Ϯ 2.9 vs. Effect of diet-induced obesity on ACh-induced dilation of arterioles. ACh-induced dilation of cremaster muscle arterioles with myogenic tone from obese rats was not altered compared with vessels from control rats (n ϭ 12-13 of each; Fig. 1A ). The roles of NO and soluble guanylate cyclase (sGC) in ACh-induced dilation was assessed using the NOS inhibitor L-NAME (100 mol/l) in combination with the sGC inhibitor ODQ (10 mol/l). L-NAME and ODQ treatment did not significantly inhibit ACh-induced dilation of arterioles from control-diet rats (Fig. 1B) , but dilation of arterioles from obese rats was significantly reduced by NOS/sGC inhibition (Fig. 1C) .
In the presence of L-NAME and ODQ, the further addition of the IK Ca and SK Ca inhibitors TRAM-34 (0.1 mol/l) and AP (0.1 mol/l) further reduced ACh-induced dilation of cremaster muscle arterioles from both control and obese rats (Fig. 1, B and C,  respectively) . In arterioles from control rats, the subsequent addition of the BK Ca blocker IBTX (0.1 mol/l) abolished the remaining ACh-induced dilation, which persisted in the presence of L-NAME, ODQ, TRAM-34, and AP (Fig. 1B) . In contrast, IBTX did not significantly further inhibit ACh-induced dilation in arterioles from obese rats in the presence of L-NAME, ODQ, and the other K Ca inhibitors (Fig. 1C) .
In arterioles from control rats, baseline diameter (i.e., myogenic tone at 70 mmHg) was not altered after treatment with L-NAME and ODQ (Fig. 1B) . In arterioles from obese rats, baseline diameter was significantly reduced from 44.5 Ϯ 1.6 to 40.1 Ϯ 1.8% by L-NAME and ODQ (P Ͻ 0.05, paired t-test n ϭ 15; Fig. 1C) . The further addition of TRAM-34 and AP did not significantly alter diameter in arterioles from control or obese rats compared with L-NAME and ODQ alone (Fig. 1, B  and C) . The addition of IBTX to L-NAME, ODQ, TRAM-34, and AP did not significantly alter diameter in arterioles from control or obese rats (Fig. 1, B and C) .
Effect of diet-induced obesity on 11,12-EET-induced dilation of arterioles. In the rat cremaster muscle arteriole, evidence suggests ACh-induced activation of BK Ca is mediated by a CYP 450 -derived metabolite of arachidonic acid, most likely 11,12-EET (43). In the current study, 11,12-EET (1-10 mol/l) caused a concentration-dependent dilation of arterioles from both control and obese rats (Fig. 2, A-C) . However, dilation to 11,12-EET (10 mol/l) was significantly reduced in arterioles from obese rats ( Fig. 2A) . IBTX alone significantly constricted arterioles from control rats (50.9 Ϯ 1.8 to 42.3 Ϯ 1.7%; P Ͻ 0.05, paired t-test; n ϭ 7 of each; Fig. 2B ) but not obese rats (51.6 Ϯ 3.4 to 47.8 Ϯ 2.1%; P Ͼ 0.05; n ϭ 5-7 of each; Fig. 2C ). IBTX significantly inhibited dilation to 11,12-EET in arterioles from control but not obese rats (Fig; 2, B and  C, respectively) .
Effect of diet-induced obesity on SNP-and 8-bromo-cGMPinduced dilation of arterioles, responses to L-NAME and ODQ, and removal of the endothelium. To investigate possible, obesity-induced changes in smooth muscle responsiveness to NO, cumulative concentration-response curves to the NO donor SNP (1 nmol/l-10 mol/l) were performed in the absence and presence of IBTX (0.1 mol/l). Maximum dilation induced by SNP in arterioles from obese rats was not significantly different to control (obese: 86.8 Ϯ 2.5 vs. control: 77.5 Ϯ 3.9%, respectively; P Ͼ 0.05, unpaired t-test; n ϭ 10 of each; Fig. 3A) . Dilation caused by lesser concentrations of SNP (0.1 and 1 mol/l) was significantly increased in arterioles from obese rats compared with control. There was no significant difference in pEC 50 between the two groups (control: 7.0 Ϯ 0.2 vs. obese: 7.2 Ϯ 0.1; P Ͼ 0.05, unpaired t-test; n ϭ 10 of each; Fig. 3A) . IBTX significantly constricted arterioles from control but not obese rats (control diameter: 45.0 Ϯ 2.1%; control ϩ IBTX: 32.9 Ϯ 1.8%; P Ͻ 0.05, paired t-test; n ϭ 8; obese diameter: 49.3 Ϯ 1.8%; obese ϩ IBTX: 46.6 Ϯ 2.8%; P Ͼ 0.05, paired t-test; n ϭ 9). IBTX significantly inhibited but did not abolish dilation to SNP in arterioles from both control and obese rats (n ϭ 8 -9 of each; Fig. 3A) .
Vasodilation induced by 1 mmol/l 8-bromo-cGMP in arterioles from obese rats was not significantly different from control (Fig. 3B) . Dilation to 1 mmol/l 8-bromo-cGMP was abolished by IBTX in arterioles from both control and obese rats, with IBTX also significantly constricting arterioles from control but not obese rats in these experiments (Fig. 3B) .
Endothelium denudation did not alter diameter of arterioles from control rats (Fig. 3C) . Diameter was significantly reduced in endothelium-denuded arterioles from obese rats (baseline: 47.5 Ϯ 2.1% vs. endothelium denuded: 38.1 Ϯ 2.7%; P Ͻ 0.05, paired t-test; n ϭ 4 of each; Fig. 3C ). In a separate series of experiments, endothelium-intact vessels were treated with L-NAME (100 mol/l) alone followed by the addition of ODQ (10 mol/l) to determine whether increased NOS activity, or sGC activity, or both, was responsible for the effect of L-NAME and ODQ on the diameter of vessels from obese rats. Neither L-NAME alone, nor the subsequent addition of ODQ, altered the diameter of cremaster muscle arterioles from control rats (Fig.  3D) . In contrast, L-NAME alone caused a significant constriction of arterioles from obese rats and the addition of ODQ caused a further reduction in diameter (Fig. 3D) .
Effect of diet-induced obesity on eNOS expression, NOS activity, and sGC activity. Western blotting of membrane-enriched extracts of cremaster muscle arteriole samples showed that eNOS expression was similar in vessels from obese and control rats (relative to actin; Fig. 4 , A and B, respectively). Total NOS enzyme activity was measured in membrane-enriched extracts of cremaster muscle arterioles from both control and obese rats by the conversion of L-
In these extracts, NOS activity in arterioles from obese rats was significantly increased compared with control (Fig. 4C) . The activity of sGC was assessed by measurement of cGMP by ELISA. There was no difference in the concentration of cGMP present in cremaster muscle arterioles from control and obese rats (Fig. 4D) .
Effect of diet-induced obesity on caveolin expression. Western blotting was performed to measure caveolin expression in cremaster muscle arteriole samples. In addition to existing as monomers, caveolins can associate in stable homo-and heterooligomeric complexes that in conjunction with cholesterol, sphingolipids, and glycosphingolipids promote the formation of caveolae. These complexes are tightly packed, insoluble in nonionic detergents (64) and are resistant to dissociation in SDS and 2-mercaptoethanol unless boiled (35, 46, 62) . Caveolin-1 forms homo-oligomeric complexes and hetero-oligomeric complexes with caveolin-2 (64). Caveolin-2 does not form homo-oligomeric complexes and requires either caveolin-1 or caveolin-3 to oligomerize (47, 55) .
In the present study, expression of caveolin-1, -2 and -3 monomers in membrane-enriched extracts of arteriole samples were not altered by obesity (relative to actin; Fig. 5, A-F) . In intact cells and arteries, however, caveolins-1 and -2 also exist within caveolae as oligomeric complexes of high molecular weight (35) . Expression of caveolin-1 oligomers (Fig. 5, A and B) and caveolin-2 oligomers (Fig. 5, C and D) were increased in whole arterioles from obese rats compared with control. Oligomers of caveolin-3 were not apparent (Fig. 5, E and F) .
Detection and localization of caveolae, eNOS, BK Ca ␣-subunit, and caveolins by immunohistochemistry and electron microscopy. Electron micrographs of the arteriolar wall showed caveolae, as omega-shaped membrane invaginations, and accumulations of the same-sized cytoplasmic vesicle-like structures adjacent to the cell membrane (54) were present on the luminal and abluminal/adventitial surface of endothelial and smooth muscle cells of cremaster arterioles from control (Fig. 6, 1 ) and obese rats (Fig. 6, 2) . The mean diameter of caveolae did not differ between control and obese rats, either in endothelial (control: Fig. 2 . Responses to 11,12-epoxyeicosatrienoic acid (11, in arterioles maintained at 70 mmHg from control and obese rats (A; n ϭ 7 of each). Diameter is expressed as a percentage of the passive diameter. Data expressed as means Ϯ SE. Dilation to 11,12-EET in the absence and presence of IBTX in arterioles from control (B; n ϭ 7 ϩ IBTX) and obese rats (C; n ϭ 5 ϩ IBTX). #11,12-EET-induced dilation was significantly reduced in arterioles from obese rats compared with control (P Ͻ 0.05, unpaired t-test); *significant inhibition by IBTX; †dilation to 10 mol/l 11,12-EET was significantly increased compared with 1 mol/l and baseline (P Ͻ 0.05, one-way repeated measures ANOVA with Bonferroni posttest).
72 Ϯ 1 nm; obese: 72 Ϯ 2 nm) or smooth muscle cells (control: 72 Ϯ 0.4 nm; obese: 72 Ϯ 2 nm; n ϭ 10 for all; P Ͼ 0.
05, t-test).
Extensive counting of caveolae showed a decreased density in endothelial cells of arterioles from obese rats compared with those from control ( Fig. 6 ; Table 1 ). There was no significant effect of obesity on overall caveolae density in smooth muscle ( Fig. 6 ; Table 1 ). Although there was an increase in the density of caveolae at the longtitudinal ends of the cells ( Fig. 6 ; Table  1 ), as these represent a small proportion of the overall surface area of the elongated, spindle-shaped smooth muscle cells, an increase in caveolae at the ends of the cells is unlikely to affect overall medial caveolae density.
Confocal immunohistochemistry in intact vessels demonstrated endothelial cell (Fig. 7A ) and smooth muscle cell (Fig. 7B) caveolin-1 localization at the membrane and within the cytoplasm. Ultrastructural immuno-electron microscopy showed a similar distribution of caveolin-1 (control only; Fig. 7C ), and doubleimmuno-electron microscopy labeling showed the BK Ca ␣-subunit was present in the smooth muscle only (i.e., absent in the Fig. 3 . Cumulative sodium nitroprusside (SNP) concentration-response curves (A; n ϭ 10 of each) and dilation to 8-bromo-cGMP (1 mmol/l; B; n ϭ 4 of each) in cremaster muscle arterioles maintained at 70 mmHg from control and obese rats in the absence and presence of IBTX (A: n ϭ 8 -9 of each; B: n ϭ 3-4 of each); the effect of endothelium denudation (C; n ϭ 4 of each) and the effect of LN and ODQ on myogenic tone of cremaster muscle arterioles maintained at 70 mmHg from control and obese rats (D; n ϭ 6 -8 of each). Diameter is expressed as a percentage of the passive diameter. Data expressed as means Ϯ SE. #Dilation to SNP was significantly increased in arterioles from obese rats compared with control; * and †significant inhibition of SNP or 8-bromo-cGMP by IBTX in arterioles from control and obese rats, respectively (P Ͻ 0.05; A: two-way ANOVA with Bonferroni posttest; B: one-way repeated measures ANOVA or one-way ANOVA with Bonferroni posttest as appropriate). §Diameter was decreased in endothelium denuded arterioles from obese rats (P Ͻ 0.05, paired t-test); ␦LN significantly constricted arterioles from obese rats compared with baseline; further constriction with the addition of ODQ (P Ͻ 0.05, one-way repeated-measures ANOVA with Bonferroni posttest; n ϭ 6). endothelium) and localized at the membrane and within the cytoplasm (Fig. 7D) . Localized BK Ca ␣-subunit labeling appeared to be spatially associated with caveolin-1 (and presumably, in caveolae), while apparent BK Ca ␣-subunit labeling not associated with caveolin-1 was observed also (Fig. 7D) . Confocal immunohistochemistry showed caveolin-2 at a low level in endothelium and apparent higher level in the smooth muscle (Fig. 7, E and F,  respectively) , while caveolin-3 was present in the smooth muscle only (Fig. 7G) and eNOS was localized to the endothelium and absent in the muscle (Fig. 7H) .
DISCUSSION
Obesity is an established risk-factor for vascular disease, with dysfunction of the vascular endothelium an early and important symptom. BK Ca are important mediators of both endothelium-dependent and -independent vasodilation. In rat D) , and caveolin-3 monomer (E and F) in cremaster muscle arterioles from control (n ϭ 4) and obese (n ϭ 3) rats. Actin blots in A, C, and E are from the same blot and represent appropriate loading controls; blots were stripped and reprobed for caveolin subtypes. Columns represent means Ϯ SE. *Significant difference compared with control (P Ͻ 0.05, unpaired t-test).
cremaster muscle arterioles, BK Ca ␤ 1 -subunit expression and function were reduced by dietary obesity and BK Ca -mediated regulation of myogenic tone was abolished (32) . This study further examined the effect of diet-induced obesity on cremaster muscle arteriole function and in particular BK Ca -mediated vasodilatation. Dietary obesity did not alter the overall response of the arterioles to the endothelium-dependent vasodilator ACh, but BK Ca -mediated dilation was greatly attenuated, whereas the relative contribution of NO to ACh-induced dilation was increased, with evidence suggesting increased NOS activity may compensate for decreased BK Ca function in cremaster muscle arterioles from rats with dietary obesity. These changes were associated with an increased expression of caveolin-1 and -2 oligomers in whole artery extracts and a decreased number of caveolae in endothelial cells of arteries from obese rats.
ACh-induced dilation of isolated, pressurized rat cremaster muscle arterioles from control-diet rats was found to be dependent on activation of BK Ca , IK Ca , and SK Ca with no quantifiable role for NO, as demonstrated by selective antagonists or blocking agents. Similar findings were made in another study using this vessel from younger, Wistar rats (43) , where the NOS inhibitor L-NAME caused a modest inhibition of ACh-induced dilation. In the rat cremaster muscle arteriole, ACh was shown to activate BK Ca through a CYP 450 -metabolite of arachidonic acid, most likely 11,12-EET (43). In the current study, the BK Ca inhibitor IBTX failed to reduce ACh-induced dilation of cremaster muscle arterioles from obese rats and 11,12-EET-induced, BK Ca -mediated dilation of these arterioles was also greatly attenuated, with the (modest) remaining EETinduced dilation being IBTX insensitive. Coupled with our earlier findings (32) , this suggests that activation of BK Ca by 11,12-EET in this vessel is dependent on the ␤ 1 -subunit. EETs may activate BK Ca through a G-protein-coupled receptor mechanism (8) or through direct activation of transient receptor potential channels and subsequent generation of smooth muscle cell Ca 2ϩ sparks (8, 14) . The findings of the present study are consistent with the latter mechanism as the ␤ 1 -subunit regulates Ca 2ϩ sensitivity of BK Ca . In a recent study (75) , Ca 2ϩ sparks could not be detected in smooth muscle cells isolated from the rat cremaster muscle arteriole, although caffeine could stimulate Ca 2ϩ sparks in these cells. Inhibition of the BK Ca -mediated component of endotheliumdependent, ACh-induced dilation of cremaster muscle arterioles from obese rats appeared to be compensated by an increased NO-mediated component. Expression of eNOS was not altered by obesity; however, NOS activity was significantly increased in cremaster muscle arterioles from obese rats. NOS expression or activity could not be ascribed to the endothelium directly, as these assays were performed using membraneenriched fractions of whole arterioles and the activity assay does not measure eNOS specifically and could be attributable to increased activity of inducible NOS (68) or other NOS isoforms. However, immunohistochemistry showed eNOS was localized to the endothelium and removal of the endothelium constricted arterioles from obese rats only, suggesting the obesity-induced increase in NOS activity was localized to the endothelium.
These findings are somewhat atypical as previous studies in a variety of vessels from several models of obesity have shown reduced NO-mediated dilation (16, 26, 37, 38, 49, 69, 73) . However, the observations of the current study are highly relevant in terms of the vessel studied, the model of obesity used, and obesity studies in general. The response of the rat cremaster muscle artery suggests vascular heterogeneity in response to obesity as, in contrast to the cremaster muscle artery, reduced NO-mediated, endothelium-dependent dilation was observed in saphenous arteries (9) and middle cerebral arteries (L. Howitt, Values are means Ϯ SE. Caveolae density is per m 2 of cell surface. For details of n (in parenthesis), see MATERIALS AND METHODS. *P Ͻ 0.05, significant compared with control. Fig. 7 . Caveolins-1, -2, -3, eNOS, and large-conductance Ca 2ϩ -activated K ϩ channel (BKCa) ␣-subunit distribution in rat cremaster muscle arterioles from control rats. Confocal (intact vessel) and ultrastructural immunohistochemistry demonstrates EC and SMC (A-D) and caveolin-1 (Cav-1) localization at the membrane and within the cytoplasm (C, 10 nm Au and inset; D, 5 nm Au and inset, examples at arrowheads); and double labeling with BKCa ␣-subunit, which is localized at the membrane and within the cytoplasm in the smooth muscle (D; 10 nm Au and inset, examples at arrows); and absent in the endothelium. Confocal immunohistochemistry shows caveolin-2 (Cav-2) at a low level in endothelium and apparent higher level in the smooth muscle (E and F, respectively), while caveolin-3 (Cav-3) was present in the smooth muscle (G), and not observed in endothelium (G, top inset). eNOS was localized to the endothelium and absent in the muscle (H, inset). S. L. Sandow, M. J. Morris, and T. V. Murphy, unpublished data) from the same cohort of diet-induced obese rats used in these studies. Supporting the idea of heterogeneity in responses to obesity, increased NOS activity was recently demonstrated in coronary arteries from obese Zucker rats (11) in contrast to arteries from other vascular beds. Furthermore, the finding of increased NO-mediated, endothelium-dependent vasodilation in obesity or related hyperinsulinemic conditions such as diabetes, while infrequent, is not unique. Increased eNOS phosphorylation, activity, and NO-mediated vasodilation was reported in mesenteric arteries from rats with portal hypertension (33) , and NOmediated vasodilation is also enhanced in the early stages of diabetes (30, 42, 52) . In keeping with observations that NOS activity may be enhanced in the early, developing stages of diabetes but decreased with longer duration of the disease (52), it is quite possible that the duration of this well-characterized dietary model of obesity and observations reported in the study represent an intermediate or partial adaptive state in the response of the cremaster muscle artery to diet-induced obesity. A longer duration of the dietary period (i.e., Ͼ20 wk) may lead to the development of further systemic inflammation, oxidative stress, microvascular rarefaction, worsened hypertension, and other adaptations causing more obvious vascular dysfunction, typically observed in models such as the Zucker rat (17, 18, 23, 25, 26, 66, 69, 73, 76) .
The factors or mechanisms underlying increased NOS activity in the present study are unclear. Post-translational regulation of eNOS may be mediated through phosphorylation at a large number of sites, some of which have been associated with increased eNOS activity and NO release (40, 45) . Plasma concentrations of insulin and leptin were increased in the current study, and both hormones were shown to phosphorylate NOS and increase NO production in rat adipocytes (44) , although more recent investigations have associated hyperinsulinemia and insulin resistance with decreased activation of vascular eNOS via the phosphoinositide 3-kinase/Akt pathway (69), including a study in cremaster muscle arterioles from Zucker rats (19) . Further studies are required to determine whether insulin, leptin, or another obesity-associated factor stimulates increased NOS and reduced BK Ca ␤ 1 -subunit activity in cremaster muscle arterioles and to clarify the mechanisms involved.
SNP-induced dilation was also enhanced in arterioles from obese rats and ODQ constricted these arterioles, suggesting an increase in sGC activity, but there was no apparent increase in sGC activity as measured by the concentration of cGMP in whole arteries. Responses to 8-bromo-cGMP were similar in arteries from both control and obese rats, suggesting that responses postsGC activation were not affected by diet-induced obesity. Increased SNP-induced dilation was also observed in coronary arterioles from rats with diet-induced obesity (36) and in the forearm vasculature of humans with obesity-associated hypertension (27) . In rat coronary arterioles, the HFD did not alter eNOS or sGC ␤ 1 -subunit protein expression or basal cGMP levels; however, the sensitivity of sGC to nitro-vasodilators was increased (36) . Interestingly, SNP and 8-bromo-cGMPinduced dilations of the rat cremaster arteriole, despite being mediated at least partially through BK Ca , were not inhibited by obesity in the present study. Coupled with the findings of unaltered ␣-subunit expression and function in cremaster muscle arterioles from obese rats (32) , this suggests activation of BK Ca by these agents does not involve the ␤ 1 -subunit in this vessel, but the ␣-subunit only, presumably via protein kinase G-mediated phosphorylation (72) .
Both L-NAME alone and the addition of ODQ significantly constricted arterioles from obese, but not control rats, suggesting basal NOS activity modulated myogenic tone of the cremaster muscle arteriole in the obese animals. This was supported by the observation that endothelium denudation significantly increased myogenic tone of arterioles from obese rats only. Obesity did not affect the overall level of myogenic tone in cremaster muscle arterioles, suggesting increased basal NOS activity compensates for decreased BK Ca function in regulating pressure-induced myogenic tone in this vessel (32) .
Caveolae and their structural proteins, the caveolins, are increasingly recognized as key regulators of cell signaling proteins and mechanisms, including endothelium-derived vasoactive factors (10, 13) . Caveolin interacts with a diversity of channels and signaling molecules (reviewed by Ref. 50) including connexins (65) , integrins (74), BK Ca (2), and eNOS (13) . Caveolins also have roles in the assembly and physical coupling between ion channels and signaling complexes in vascular tissues (1) . In the present study, expression of caveolin-1 and caveolin-2 oligomers was increased in whole artery extracts from obese rats while expression of caveolin monomers was not altered. Complexing between caveolin-1 and -2 is a dynamic process involving the formation of larger and increasingly insoluble oligomers, increased phosphorylation of caveolin-2, and transport to the cell membrane (63) . Caveolae are generated by sequential assembly of these caveolin oligomers in the endoplasmic reticulum, Golgi apparatus and during transit to the plasma membrane. During these stages, increasingly larger sized oligomers of caveolins are assembled with cholesterol, membrane lipids, and other proteins. The stable homo-and hetero-oligomeric complexes promote the formation of caveolae. Therefore, increased expression of caveolin oligomers would conceivably result in an increase in caveolae. An increase in caveolae density was observed at the ends of smooth muscle cells, however, overall caveolae density was not altered in the arteries from obese rats compared with controls, with caveolae density in endothelial cells being decreased, suggesting caveolae expression is regulated and localized at the subcellular level.
In terms of caveolae and caveolin interaction with signaling pathways, our observations were associative rather than demonstrative of a functional relationship. Ultrastructural data showed a close spatial relationship between caveolin-1 and a proportion of BK Ca ␣-subunits present in the smooth muscle of rat cremaster arterioles. Reduced caveolin-1 expression (through either gene knockout or diet-induced obesity) has been associated with increased BK Ca activity in rat coronary and mouse gracilis muscle and cerebral arterioles (1, 20) . The authors concluded caveolin-1 regulated activation of BK Ca by Ca 2ϩ -sparks (1) and EDHF (20) in these vessels. These concepts are consistent with the observations of the present study, with increased caveolin-1 oligomer formation, and increased caveolae density in the "ends" of smooth muscle cells associated with decreased BK Ca activity. In contrast to its effects on BK Ca activity in the smooth muscle cells, increased caveolin-1 expression in the endothelium is typically associated with reduced NOS activity (13) . Although expression of caveolin-1 and caveolin-2 oligomers was increased in whole artery extracts from obese rats, the density of caveolae was reduced in the endothelium of these vessels while eNOS expression (localized to the endothelium) was not altered, suggesting a decrease in the ratio of caveolin-1 oligomers to eNOS in endothelial cell caveloae, which may have contributed to increased NOS activity. Furthermore and as discussed previously (32) , there are several possible factors that could have contributed to altered BK Ca and NOS activity in vessels from obese rats besides or in addition to caveolins, including decreased expression of the BK Ca ␤ 1 -subunit or, in the case of NOS, phosphorylation of the NOS enzyme and other posttranslational modification or increased inducible NOS expression/activity.
In cremaster muscle arterioles from obese rats ACh-induced dilation was maintained, although the relative contributions of NO and BK Ca were altered. In control-diet rats, ACh-induced dilation was dependent on BK Ca , IK Ca , and SK Ca with no role for NO. Dietary obesity caused a decrease in BK Ca activation by ACh and its mediator 11,12-EET, consistent with 11,12-EET activating the ␤ 1 -subunit of BK Ca . The decreased BK Ca component was compensated by increased NOS activity and an increased contribution of NO to endothelium-dependent dilation. Increased basal NO production from the endothelium modulated myogenic tone in arterioles from obese, but not control rats, apparently compensating for decreased BK Camediated regulation of tone. These alterations in NOS and BK Ca activity were associated with increased overall expression of caveolin-1 and -2 oligomers, decreased caveolae density in the endothelium, and increased caveolae density in the longitudinal ends of smooth muscle cells. Such data emphasize the complexity and diversity of arterial physiology and response to dietary obesity (9, 28) .
